| Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ... Biomarkers in medicine 6 (4), 419-430, 2012 | 334 | 2012 |
| Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment AH Simonsen, J McGuire, O Hansson, H Zetterberg, VN Podust, ... Archives of neurology 64 (3), 366-370, 2007 | 164 | 2007 |
| Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia AH Simonsen, SK Herukka, N Andreasen, I Baldeiras, M Bjerke, ... Alzheimer's & Dementia 13 (3), 274-284, 2017 | 163 | 2017 |
| Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF U Rüetschi, H Zetterberg, VN Podust, J Gottfries, S Li, AH Simonsen, ... Experimental neurology 196 (2), 273-281, 2005 | 149 | 2005 |
| Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment SK Herukka, AH Simonsen, N Andreasen, I Baldeiras, M Bjerke, ... Alzheimer's & Dementia 13 (3), 285-295, 2017 | 148 | 2017 |
| Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease AH Simonsen, J McGuire, VN Podust, H Davies, L Minthon, I Skoog, ... Neurobiology of aging 29 (7), 961-968, 2008 | 119 | 2008 |
| A disease state fingerprint for evaluation of Alzheimer's disease J Mattila, J Koikkalainen, A Virkki, A Simonsen, M Van Gils, G Waldemar, ... Journal of Alzheimer's Disease 27 (1), 163-176, 2011 | 116 | 2011 |
| The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature AH Simonsen, B Kuiperij, OMA El-Agnaf, S Engelborghs, SK Herukka, ... Biomarkers in medicine 10 (1), 19-34, 2016 | 115 | 2016 |
| A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for Alzheimer's disease G Brinkmalm, S Sjödin, AH Simonsen, SG Hasselbalch, H Zetterberg, ... PROTEOMICS–Clinical Applications 12 (1), 1700131, 2018 | 113 | 2018 |
| Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study A Lleó, D Alcolea, P Martínez-Lage, P Scheltens, L Parnetti, J Poirier, ... Alzheimer's & Dementia 15 (6), 742-753, 2019 | 96 | 2019 |
| Biomarkers for Alzheimer’s disease in saliva: a systematic review HS Gleerup, SG Hasselbalch, AH Simonsen Disease markers 2019, 2019 | 91 | 2019 |
| A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease versus normal aging and frontotemporal dementia AH Simonsen, J McGuire, VN Podust, NO Hagnelius, TK Nilsson, ... Dementia and geriatric cognitive disorders 24 (6), 434-440, 2007 | 90 | 2007 |
| Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma CS Jensen, JM Bahl, LB Østergaard, P Høgh, L Wermuth, A Heslegrave, ... Experimental gerontology 121, 91-98, 2019 | 85 | 2019 |
| Biochemical markers of physical exercise on mild cognitive impairment and dementia: systematic review and perspectives CS Jensen, SG Hasselbalch, G Waldemar, AH Simonsen Frontiers in Neurology 6, 150039, 2015 | 84 | 2015 |
| The potential of microRNAs as biofluid markers of neurodegenerative diseases–a systematic review PB Danborg, AH Simonsen, G Waldemar, NHH Heegaard Biomarkers 19 (4), 259-268, 2014 | 77 | 2014 |
| Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology AL Petri, AH Simonsen, TT Yip, E Hogdall, ET Fung, L Lundvall, ... Acta obstetricia et gynecologica Scandinavica 88 (1), 18-26, 2009 | 70 | 2009 |
| Pre-analytical factors influencing the stability of cerebrospinal fluid proteins AH Simonsen, JMC Bahl, PB Danborg, V Lindstrom, SO Larsen, A Grubb, ... Journal of neuroscience methods 215 (2), 234-240, 2013 | 65 | 2013 |
| Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design K Hoffmann, KS Frederiksen, NA Sobol, N Beyer, A Vogel, AH Simonsen, ... Neuroepidemiology 41 (3-4), 198-207, 2013 | 64 | 2013 |
| Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise CS Jensen, AH Simonsen, V Siersma, N Beyer, KS Frederiksen, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 60 | 2019 |
| Cerebrospinal fluid amyloid beta and tau concentrations are not modulated by 16 weeks of moderate-to high-intensity physical exercise in patients with Alzheimer disease C Steen Jensen, E Portelius, V Siersma, P Høgh, L Wermuth, K Blennow, ... Dementia and geriatric cognitive disorders 42 (3-4), 146-158, 2016 | 52 | 2016 |
Peter HøghNeurology, University Hospital Copenhagen, Rigshospitalet, RoskildeΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα dadlnet.dk
